September 2021

breaking news

New hope – a potential new treatment for sepsis

Researchers from California have identified molecular biomarkers, pathways and immune cell dynamics associated with sepsis that can be potentially targeted in order to prevent death from and develop new treatments…

ChelekaSeptember 30, 2021

breaking news

Identification of D6R and C5aR2 as key molecules with the potential to combat inflammatory diseases

Researchers have identified key molecules within the immune system that have the potential, through their use, to combat inflammation implicated in chronic diseases including COVID-19, cancers and...

ChelekaSeptember 28, 2021

breaking news

Microglial cells – immune cells of the CNS breaking down harmful proteins in the brain

Researchers from the University of Bonn, the German Center for Neurodegenerative Diseases (DZNE), and the Institut François Jacob in France have identified a mechanism describing α-syn accumulation and microglial degradation.

ChelekaSeptember 24, 2021

breaking news

A new cell type contributing to inflammatory skin diseases

In an interesting discovery, an international team of researchers have identified and described a new cell type in human skin that contributes to inflammatory skin diseases such as atopic dermatitis…

ChelekaSeptember 21, 2021

breaking news

How does vitamin A enter our intestinal immune cells and what are the implications?

Researchers from the University of Texas Southwestern Medical Center have discovered how vitamin A enters immune cells in the intestines. Implications - improving vaccine efficacy to the potential treatment of…

ChelekaSeptember 17, 2021

breaking news

Neutrophilic aid – extracellular traps to enhance macrophage directed bacterial killing

Recently, researchers have identified a novel antibacterial mechanism, potentially paving the way for new therapeutics to combat Staphylococcus aureus infection and other bacterial infection.

ChelekaSeptember 15, 2021

breaking news

A new tool for predicting COVID-19 severity and prognosis

Through the investigation of novel biological features explaining COVID-19 severity and prognosis (death and disease progression), researchers have developed a novel predictive tool which they have made publicly available...

ChelekaSeptember 10, 2021

breaking news

Ad26.CoV2.S vaccine significantly boosts pre-existing SARS-CoV-2 specific antibodies but not CD4 T cell immune responses

8 September 2021 In a recent Pre-print, Keeton et al., examined the effect of prior infection with ancestral (D614G) or Beta variants on Ad26.COV2.S immunogenicity approximately 28 days...

ChelekaSeptember 8, 2021

breaking news

A potential new biomarker for Preeclampsia

3 September 2021 Preeclampsia (PE) is a devastating disorder which effects more than 3-5% of pregnancies worldwide and remains to be one of the leading causes of global maternal and…

ChelekaSeptember 3, 2021

New hope – a potential new treatment for sepsis

Identification of D6R and C5aR2 as key molecules with the potential to combat inflammatory diseases

Microglial cells – immune cells of the CNS breaking down harmful proteins in the brain

A new cell type contributing to inflammatory skin diseases

How does vitamin A enter our intestinal immune cells and what are the implications?

Neutrophilic aid – extracellular traps to enhance macrophage directed bacterial killing

A new tool for predicting COVID-19 severity and prognosis

Ad26.CoV2.S vaccine significantly boosts pre-existing SARS-CoV-2 specific antibodies but not CD4 T cell immune responses

A potential new biomarker for Preeclampsia

Advancing Global Online Immunology Education for 20 years

Join our Newsletter

Advancing Global Immunology Education